Impact on quality of life during an allergen challenge research trial. (Q48750577)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10437814%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

title

Impact on quality of life during an allergen challenge research trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10437814%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10437814%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

Day JH

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10437814%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

Lundie MJ

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10437814%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

publication date

1 July 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10437814%20AND%20SRC:MED&resulttype=core&format=json

Annals of Allergy, Asthma & Immunology

11 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10437814%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10437814%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10437814%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

page(s)

33-39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10437814%20AND%20SRC:MED&resulttype=core&format=json

Effect of concurrent sucralfate administration on the absorption of erythromycin

11 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963510-7

7 January 2021

Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: development and testing of a questionnaire for clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963510-7

7 January 2021

The relationships between nasal hyperreactivity, quality of life, and nasal symptoms in patients with perennial allergic rhinitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963510-7

7 January 2021

Measuring health-related quality of life in rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963510-7

7 January 2021

Influence of asthma or allergies on the utilization of health care resources and quality of life of college students.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963510-7

7 January 2021

Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963510-7

7 January 2021

Measuring quality of life in children with rhinoconjunctivitis☆☆☆★★★

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963510-7

7 January 2021

Impact of upper respiratory allergic diseases on quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963510-7

7 January 2021

Quality of life in adults and children with asthma and rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963510-7

7 January 2021

Improvement of quality of life by treatment with cetirizine in patients with perennial allergic rhinitis as determined by a French version of the SF-36 questionnaire.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963510-7

7 January 2021

Intranasal fluticasone propionate. A reappraisal of its pharmacology and clinical efficacy in the treatment of rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963510-7

7 January 2021

Model for outcomes assessment of antihistamine use for seasonal allergic rhinitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963510-7

7 January 2021

Ipratropium bromide aqueous nasal spray for patients with perennial allergic rhinitis: a study of its effect on their symptoms, quality of life, and nasal cytology

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963510-7

7 January 2021

Sodium cromoglycate eye drops: regular versus "as needed" use in the treatment of seasonal allergic conjunctivitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963510-7

7 January 2021

Long-term treatment of perennial allergic rhinitis with ipratropium bromide nasal spray 0.06%

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963510-7

7 January 2021

Ragweed allergic rhinitis and the paranasal sinuses. A computed tomographic study.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963510-7

7 January 2021

Comparison of beclomethasone dipropionate aqueous nasal spray, astemizole, and the combination in the prophylactic treatment of ragweed pollen-induced rhinoconjunctivitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963510-7

7 January 2021

Aqueous beclomethasone diproprionate nasal spray: regular versus "as required" use in the treatment of seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963510-7

7 January 2021

Aqueous beclomethasone dipropionate in the treatment of ragweed pollen-induced rhinitis: further exploration of "as needed" use.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963510-7

7 January 2021

Efficacy and safety of loratadine plus pseudoephedrine in patients with seasonal allergic rhinitis and mild asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963510-7

7 January 2021

Sedative effects of antihistamines: safety, performance, learning, and quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963510-7

7 January 2021

Onset of action and efficacy of terfenadine, astemizole, cetirizine, and loratadine for the relief of symptoms of allergic rhinitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963510-7

7 January 2021

Onset of Action, Efficacy, and Safety of a Single Dose of Fexofenadine Hydrochloride for Ragweed Allergy Using an Environmental Exposure Unit

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963510-7

7 January 2021

Efficacy of immunotherapy to ragweed antigen tested by controlled antigen exposure

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963510-7

7 January 2021

A randomized, double-blind, placebo-controlled, controlled antigen delivery study of the onset of action of aerosolized triamcinolone acetonide nasal spray in subjects with ragweed-induced allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963510-7

7 January 2021

Issues in quality-of-life measurement in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963510-7

7 January 2021

Factors of importance when evaluating quality of life in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963510-7

7 January 2021

Validating the SF-36 health survey questionnaire: new outcome measure for primary care

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963510-7

7 January 2021

The MOS short-form general health survey. Reliability and validity in a patient population

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963510-7

7 January 2021

The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963510-7

7 January 2021

The validity and relative precision of MOS short- and long-form health status scales and Dartmouth COOP charts. Results from the Medical Outcomes Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963510-7

7 January 2021

10.1016/S1081-1206(10)63510-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10437814%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10437814%20AND%20SRC:MED&resulttype=core&format=json